Zyno Solutions Revenue and Competitors
Estimated Revenue & Valuation
- Zyno Solutions's estimated annual revenue is currently $4.5M per year.
- Zyno Solutions's estimated revenue per employee is $251,000
Employee Data
- Zyno Solutions has 18 Employees.
- Zyno Solutions grew their employee count by -36% last year.
Zyno Solutions's People
Name | Title | Email/Phone |
---|---|---|
1 | Director Operations | Reveal Email/Phone |
2 | Accounting Assistant | Reveal Email/Phone |
Zyno Solutions Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $9.8M | 39 | 3% | N/A | N/A |
#2 | $8.5M | 34 | 3% | N/A | N/A |
#3 | $3M | 12 | -29% | N/A | N/A |
#4 | $5630M | 7477 | -11% | $450M | N/A |
#5 | $4.5M | 18 | 6% | N/A | N/A |
#6 | $7.2M | 57 | 27% | $29.6M | N/A |
#7 | $14.3M | 57 | -12% | N/A | N/A |
#8 | $2.3M | 18 | 6% | $44M | N/A |
#9 | $40.7M | 162 | -1% | N/A | N/A |
#10 | $45.7M | 182 | -5% | N/A | N/A |
What Is Zyno Solutions?
Zyno Solutions LLC is a leader in providing IV infusion technology and is dedicated to delivering intelligent infusion systems that provide the highest quality of care and patient safety. Zyno Solutions offers technologically advanced products for the alternate care market and provides large volume infusion pumps, ambulatory infusion pumps, integrated wireless infusion systems and IV accessories. Zyno Solutions provides these devices and systems for ambulatory infusion suites, oncology infusion suites, long-term care pharmacies, specialty pharmacies and home care providers. We offer cost effective technology solutions to support our customers evolving business and healthcare needs.
keywords:N/AN/A
Total Funding
18
Number of Employees
$4.5M
Revenue (est)
-36%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.1M | 21 | -47% | N/A |
#2 | $3.4M | 22 | -4% | N/A |
#3 | $2.3M | 23 | 0% | N/A |
#4 | $2.3M | 23 | 10% | N/A |
#5 | $1.9M | 24 | 9% | $63M |